Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01017692 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging (MRI) Interpretations for Lumbar Spinal Stenosis (LSS)
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 36
- Enrollment target
NCT01017692: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT01017692 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01017692 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The objective of this study is to establish a relationship between the degree of radiologically established anatomical stenosis and the severity of self-assessed outcome measures in patients that have undergone and MRI.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-12 |
What the finished NCT01017692 record still lists
NCT01017692 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT01017692 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01017692 about?
NCT01017692 is a clinical study titled "Magnetic Resonance Imaging (MRI) Interpretations for Lumbar Spinal Stenosis (LSS)". The objective of this study is to establish a relationship between the degree of radiologically established anatomical stenosis and the severity of self-assessed outcome measures in patients that have undergone and MRI.
What is the current status of trial NCT01017692?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2009-06. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01017692?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT01017692?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia